- My Portfolio
- News
- Markets
- Stocks: Most Actives
- Stocks: Gainers
- Stocks: Losers
- Trending Tickers
- Futures
- World Indices
- US Treasury Bonds Rates
- Currencies
- Crypto
- Top ETFs
- Top Mutual Funds
- Options: Highest Open Interest
- Options: Highest Implied Volatility
- Sectors
- Basic Materials
- Communication Services
- Consumer Cyclical
- Consumer Defensive
- Energy
- Financial Services
- Healthcare
- Industrials
- Real Estate
- Technology
- Utilities
- Research
- Personal Finance
- Videos
New on Yahoo
Yahoo Finance
Yahoo FinanceWe're continuously improving your experience and this page will be retired soon. If you rely on the content on this page, check out Screeners Beta for similar content and functionality.
The Fight Against COVID19
23.85k followers • 13 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Performance
| Watchlist | Change Today | 1 Month Return | 1 Year Return | Total Return |
|---|---|---|---|---|
| The Fight Against COVID19 | +1.96% | - | - | - |
| ^GSPC | +0.53% | +1.67% | +30.55% | +6296.46% |
13 Symbols
| Symbol | Company Name | Last Price | Change | % Change | Market Time | Volume | Avg Vol (3 month) | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 155.5 | +2.39 | +1.56% | 4:00 PM EST | 9.48M | 6.34M | 374.38B |
| ABBV | AbbVie Inc. | 171.73 | +3.97 | +2.37% | 4:00 PM EST | 5.62M | 5.44M | 303.47B |
| PFE | Pfizer Inc. | 25.13 | +0.19 | +0.76% | 4:00 PM EST | 44.70M | 36.46M | 142.41B |
| SNY | Sanofi | 47.98 | +0.20 | +0.42% | 4:00 PM EST | 1.35M | 1.88M | 121.64B |
| GILD | Gilead Sciences, Inc. | 89.76 | +1.13 | +1.27% | 4:00 PM EST | 3.90M | 6.73M | 111.87B |
| REGN | Regeneron Pharmaceuticals, Inc. | 744.5 | +1.15 | +0.15% | 4:00 PM EST | 972.99k | 693.24k | 81.81B |
| GSK | GSK plc | 33.7 | +0.35 | +1.05% | 4:00 PM EST | 7.03M | 5.64M | 68.76B |
| TAK | Takeda Pharmaceutical Company Limited | 13.33 | +0.04 | +0.30% | 4:00 PM EST | 4.01M | 1.72M | 42.97B |
| BNTX | BioNTech SE | 108.23 | +6.09 | +5.96% | 4:00 PM EST | 1.03M | 1.08M | 25.95B |
| MRNA | Moderna, Inc. | 38.25 | +1.31 | +3.55% | 4:00 PM EST | 8.88M | 6.49M | 14.72B |
| NVAX | Novavax, Inc. | 8.04 | -0.02 | -0.25% | 4:00 PM EST | 3.07M | 6.37M | 1.29B |
| VIR | Vir Biotechnology, Inc. | 6.95 | +0.21 | +3.12% | 4:00 PM EST | 1.85M | 995.56k | 957.15M |
| INO | Inovio Pharmaceuticals, Inc. | 4.06 | +0.09 | +2.27% | 4:00 PM EST | 565.15k | 320.30k | 105.97M |
Insider MonkeyWhy Is Moderna, Inc. (MRNA) Among the Worst Performing Biotech Stocks in 2024?
We recently compiled a list of the 10 Worst Performing Biotech Stocks in 2024. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other biotech stocks. Biotechnology Stocks: Navigating Volatility Amid Market Fluctuations and Industry Growth Biotechnology stocks are among the most volatile in the market due […]
Investor's Business DailyNovavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell?
Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX stock a sell?
CNW GroupHealth Canada Authorizes CARVYKTI® (ciltacabtagene autoleucel) for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received One to Three Prior Lines of Therapy
Johnson & Johnson (NYSE: JNJ) announced today that Health Canada has issued a Notice of Compliance (NOC) for CARVYKTI® (ciltacabtagene autoleucel) for the treatment of adult patients with multiple myeloma who have received one to three prior lines of therapy, including a proteasome inhibitor and an immunomodulatory agent, and who are refractory to lenalidomide.1 With this approval, CARVYKTI® becomes the first and only B-cell Maturation Antigen (BCMA)-targeted therapy approved for the treatment o